Skip to main content
Figure 3 | BMC Endocrine Disorders

Figure 3

From: Effects of aging and type 2 diabetes on resting and post occlusive hyperemia of the forearm; the impact of rosiglitazone

Figure 3

This figure illustrates the excess flow above rest during a two minute period after the release of an occlusion cuff on the brachial artery of control subjects and subjects with diabetes. Individual data points are shown on control subjects and subjects with diabetes prior to initiation of a three month administration of rosiglitazone (pre rsg) and after 2 weeks (2 w), four weeks (4 w), and three months (3 m). Data is plotted in relationship to the age of the subject. The regression lines are calculated by the method of least squares. On the control subjects the regression line was flow = -0.518 age + 77.78. Prior to administration of rosiglitazone of the subjects with diabetes the regression equation was flow = -0.253 age + 31.01. After two weeks of administration of rosiglitazone the regression equation was blood flow = -0.348 age + 41.6. After 4 weeks of rosiglitazone the regression equation was blood flow = -0.243 age + 50.27. Finally after 3 months of rosiglitazone was post occlusion flow = -0.274 age + 64.94

Back to article page